These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 21752889)
1. Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy. King KS; Chen CC; Alexopoulos DK; Whatley MA; Reynolds JC; Patronas N; Ling A; Adams KT; Xekouki P; Lando H; Stratakis CA; Pacak K J Clin Endocrinol Metab; 2011 Sep; 96(9):2779-85. PubMed ID: 21752889 [TBL] [Abstract][Full Text] [Related]
2. Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Havekes B; Eisenhofer G; Martiniova L; Adams KT; Pacak K J Clin Endocrinol Metab; 2009 Dec; 94(12):4757-67. PubMed ID: 19864450 [TBL] [Abstract][Full Text] [Related]
3. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Ling A; Eisenhofer G; Adams KT; Solis D; Lenders JW; Pacak K J Clin Oncol; 2007 Jun; 25(16):2262-9. PubMed ID: 17538171 [TBL] [Abstract][Full Text] [Related]
4. 68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI. Janssen I; Chen CC; Taieb D; Patronas NJ; Millo CM; Adams KT; Nambuba J; Herscovitch P; Sadowski SM; Fojo AT; Buchmann I; Kebebew E; Pacak K J Nucl Med; 2016 Feb; 57(2):186-91. PubMed ID: 26564322 [TBL] [Abstract][Full Text] [Related]
5. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression. Fottner C; Helisch A; Anlauf M; Rossmann H; Musholt TJ; Kreft A; Schadmand-Fischer S; Bartenstein P; Lackner KJ; Klöppel G; Schreckenberger M; Weber MM J Clin Endocrinol Metab; 2010 Jun; 95(6):2800-10. PubMed ID: 20371665 [TBL] [Abstract][Full Text] [Related]
6. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations. Zelinka T; Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Reynolds JC; Ling A; Eisenhofer G; Lazúrová I; Adams KT; Whatley MA; Widimsky J; Pacak K Endocr Relat Cancer; 2008 Mar; 15(1):311-23. PubMed ID: 18310297 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of Somatostatin Receptor Scintigraphy (Tc-[HYNIC, Tyr3]-Octreotide) and 123I-Metaiodobenzylguanidine Scintigraphy in Patients with SDHx Gene-Related Pheochromocytomas and Paragangliomas Detected by Computed Tomography. Michałowska I; Ćwikła JB; Pęczkowska M; Furmanek MI; Buscombe JR; Michalski W; Prejbisz A; Szperl M; Malinoc A; Moczulski D; Szutkowski Z; Kawecki A; Antoniewicz J; Pęczkowski P; Lewczuk A; Otto M; Cichocki A; Bednarek-Tupikowska G; Kabat M; Janaszek-Sitkowska H; Przybyłowska K; Janas J; Neumann HP; Januszewicz A Neuroendocrinology; 2015; 101(4):321-30. PubMed ID: 25791839 [TBL] [Abstract][Full Text] [Related]
9. Integrated whole-body PET/MRI with 18F-FDG, 18F-FDOPA, and 18F-FDA in paragangliomas in comparison with PET/CT: NIH first clinical experience with a single-injection, dual-modality imaging protocol. Blanchet EM; Millo C; Martucci V; Maass-Moreno R; Bluemke DA; Pacak K Clin Nucl Med; 2014 Mar; 39(3):243-50. PubMed ID: 24152658 [TBL] [Abstract][Full Text] [Related]
10. Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma. Janssen I; Blanchet EM; Adams K; Chen CC; Millo CM; Herscovitch P; Taieb D; Kebebew E; Lehnert H; Fojo AT; Pacak K Clin Cancer Res; 2015 Sep; 21(17):3888-95. PubMed ID: 25873086 [TBL] [Abstract][Full Text] [Related]
11. Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET. Binderup T; Knigge U; Loft A; Mortensen J; Pfeifer A; Federspiel B; Hansen CP; Højgaard L; Kjaer A J Nucl Med; 2010 May; 51(5):704-12. PubMed ID: 20395333 [TBL] [Abstract][Full Text] [Related]
12. Utility of FDG-PET imaging in screening for succinate dehydrogenase B and D mutation-related lesions. Kornaczewski ER; Pointon OP; Burgess JR Clin Endocrinol (Oxf); 2016 Aug; 85(2):172-9. PubMed ID: 26776272 [TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT as a predictor of hereditary head and neck paragangliomas. Blanchet EM; Gabriel S; Martucci V; Fakhry N; Chen CC; Deveze A; Millo C; Barlier A; Pertuit M; Loundou A; Pacak K; Taïeb D Eur J Clin Invest; 2014; 44(3):325-332. PubMed ID: 24422786 [TBL] [Abstract][Full Text] [Related]
14. Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up. Lepoutre-Lussey C; Caramella C; Bidault F; Déandreis D; Berdelou A; Al Ghuzlan A; Hartl D; Borget I; Gimenez-Roqueplo AP; Dumont F; Deschamps F; Nascimento C; Lumbroso J; Guillaud Bataille M; Schlumberger M; Baudin E; Leboulleux S Eur J Nucl Med Mol Imaging; 2015 May; 42(6):868-76. PubMed ID: 25676472 [TBL] [Abstract][Full Text] [Related]
15. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess. Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618 [TBL] [Abstract][Full Text] [Related]
16. Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by (18) F-FDOPA PET: focus on missed lesions. Gabriel S; Blanchet EM; Sebag F; Chen CC; Fakhry N; Deveze A; Barlier A; Morange I; Pacak K; Taïeb D Clin Endocrinol (Oxf); 2013 Aug; 79(2):170-7. PubMed ID: 23230826 [TBL] [Abstract][Full Text] [Related]
17. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography. Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Eisenhofer G; King KS; Rao JU; Wesley RA; Adams KT; Pacak K J Natl Cancer Inst; 2012 May; 104(9):700-8. PubMed ID: 22517990 [TBL] [Abstract][Full Text] [Related]
19. 111In-pentetreotide scintigraphy is superior to 123I-MIBG scintigraphy in the diagnosis and location of chemodectoma. Muros MA; Llamas-Elvira JM; Rodríguez A; Ramírez A; Gómez M; Arráez MA; Valéncia E; Vílchez R Nucl Med Commun; 1998 Aug; 19(8):735-42. PubMed ID: 9751927 [TBL] [Abstract][Full Text] [Related]